Circulating thymulin and thymosin-alpha 1 activity in pediatric acquired immune deficiency syndrome: in vivo and in vitro studies

J Pediatr. 1986 Sep;109(3):422-7. doi: 10.1016/s0022-3476(86)80111-1.

Abstract

Twenty-five children with acquired immune deficiency syndrome (AIDS) or AIDS-related complex had a characteristic pattern of T cell deficiency. Abnormally low plasma thymulin levels preceded the development of peripheral blood T cell abnormalities. In contrast to patients with congenital T cell deficiencies, our patients had elevated serum levels of thymosin-alpha 1. Treatment with thymosin fraction 5 in three children with AIDS resulted in only transient clinical and immunologic improvement.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acquired Immunodeficiency Syndrome / blood*
  • Acquired Immunodeficiency Syndrome / drug therapy
  • Acquired Immunodeficiency Syndrome / immunology
  • Child
  • Child, Preschool
  • Deltaretrovirus / immunology
  • Humans
  • In Vitro Techniques
  • Infant
  • T-Lymphocytes / immunology
  • Thymalfasin
  • Thymic Factor, Circulating / blood*
  • Thymosin / analogs & derivatives*
  • Thymosin / blood
  • Thymosin / therapeutic use
  • Thymus Hormones / blood*

Substances

  • Thymus Hormones
  • thymosin fraction 5
  • Thymosin
  • Thymic Factor, Circulating
  • Thymalfasin